Steroid use in elderly critically ill COVID-19 patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/127065 |
Resumo: | Funding Information: Support statement: This work was supported by the European Commission, APHP and Health Region West (Norway). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: C. Jung has nothing to disclose. B. Wernly has nothing to disclose. J. Fjølner has nothing to disclose. R.R. Bruno has nothing to disclose. D. Dudzinski has nothing to disclose. A. Artigas reports grants from Grifols and Fisher&Paykel, personal fees for advisory board work from Grifols, Novartis and Lilly Foundation, outside the submitted work. B. Bollen Pinto has nothing to disclose. J.C. Schefold has nothing to disclose. G. Wolff has nothing to disclose. M. Kelm has nothing to disclose. M. Beil has nothing to disclose. S. Sigal has nothing to disclose. P.V. van Heerden has nothing to disclose. W. Szczeklik has nothing to disclose. M. Czuczwar has nothing to disclose. M. Elhadi has nothing to disclose. M. Joannidis has nothing to disclose. S. Oeyen has nothing to disclose. T. Zafeiridis has nothing to disclose. B. Marsh has nothing to disclose. F.H. Andersen has nothing to disclose. R. Moreno has nothing to disclose. M. Cecconi has nothing to disclose. S. Leaver has nothing to disclose. A. Boumendil has nothing to disclose. D.W. De Lange has nothing to disclose. B. Guidet has nothing to disclose. H. Flaatten has nothing to disclose. |
id |
RCAP_3e5080ddcd40d762880bf5309eb6928a |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/127065 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Steroid use in elderly critically ill COVID-19 patientsPulmonary and Respiratory MedicineFunding Information: Support statement: This work was supported by the European Commission, APHP and Health Region West (Norway). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: C. Jung has nothing to disclose. B. Wernly has nothing to disclose. J. Fjølner has nothing to disclose. R.R. Bruno has nothing to disclose. D. Dudzinski has nothing to disclose. A. Artigas reports grants from Grifols and Fisher&Paykel, personal fees for advisory board work from Grifols, Novartis and Lilly Foundation, outside the submitted work. B. Bollen Pinto has nothing to disclose. J.C. Schefold has nothing to disclose. G. Wolff has nothing to disclose. M. Kelm has nothing to disclose. M. Beil has nothing to disclose. S. Sigal has nothing to disclose. P.V. van Heerden has nothing to disclose. W. Szczeklik has nothing to disclose. M. Czuczwar has nothing to disclose. M. Elhadi has nothing to disclose. M. Joannidis has nothing to disclose. S. Oeyen has nothing to disclose. T. Zafeiridis has nothing to disclose. B. Marsh has nothing to disclose. F.H. Andersen has nothing to disclose. R. Moreno has nothing to disclose. M. Cecconi has nothing to disclose. S. Leaver has nothing to disclose. A. Boumendil has nothing to disclose. D.W. De Lange has nothing to disclose. B. Guidet has nothing to disclose. H. Flaatten has nothing to disclose.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNJung, ChristianWernly, BernhardFjølner, JesperBruno, Raphael RomanoDudzinski, DavidArtigas, AntonioPinto, Bernardo BollenSchefold, Joerg C.Wolff, GeorgKelm, MalteBeil, MichaelSigal, Svirivan Heerden, Peter VernonSzczeklik, WojciechCzuczwar, MiroslawElhadi, MuhammedJoannidis, MichaelOeyen, SandraZafeiridis, TilemachosMarsh, BrianAndersen, Finn H.Moreno, RuiCecconi, MaurizioLeaver, SusannahBoumendil, ArianeDe Lange, Dylan W.Guidet, BertrandFlaatten, Hans2021-11-03T05:03:06Z2021-10-012021-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/127065eng0903-1936PURE: 34379126https://doi.org/10.1183/13993003.00979-2021info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T17:56:55Zoai:run.unl.pt:10362/127065Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T17:56:55Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Steroid use in elderly critically ill COVID-19 patients |
title |
Steroid use in elderly critically ill COVID-19 patients |
spellingShingle |
Steroid use in elderly critically ill COVID-19 patients Jung, Christian Pulmonary and Respiratory Medicine |
title_short |
Steroid use in elderly critically ill COVID-19 patients |
title_full |
Steroid use in elderly critically ill COVID-19 patients |
title_fullStr |
Steroid use in elderly critically ill COVID-19 patients |
title_full_unstemmed |
Steroid use in elderly critically ill COVID-19 patients |
title_sort |
Steroid use in elderly critically ill COVID-19 patients |
author |
Jung, Christian |
author_facet |
Jung, Christian Wernly, Bernhard Fjølner, Jesper Bruno, Raphael Romano Dudzinski, David Artigas, Antonio Pinto, Bernardo Bollen Schefold, Joerg C. Wolff, Georg Kelm, Malte Beil, Michael Sigal, Sviri van Heerden, Peter Vernon Szczeklik, Wojciech Czuczwar, Miroslaw Elhadi, Muhammed Joannidis, Michael Oeyen, Sandra Zafeiridis, Tilemachos Marsh, Brian Andersen, Finn H. Moreno, Rui Cecconi, Maurizio Leaver, Susannah Boumendil, Ariane De Lange, Dylan W. Guidet, Bertrand Flaatten, Hans |
author_role |
author |
author2 |
Wernly, Bernhard Fjølner, Jesper Bruno, Raphael Romano Dudzinski, David Artigas, Antonio Pinto, Bernardo Bollen Schefold, Joerg C. Wolff, Georg Kelm, Malte Beil, Michael Sigal, Sviri van Heerden, Peter Vernon Szczeklik, Wojciech Czuczwar, Miroslaw Elhadi, Muhammed Joannidis, Michael Oeyen, Sandra Zafeiridis, Tilemachos Marsh, Brian Andersen, Finn H. Moreno, Rui Cecconi, Maurizio Leaver, Susannah Boumendil, Ariane De Lange, Dylan W. Guidet, Bertrand Flaatten, Hans |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Jung, Christian Wernly, Bernhard Fjølner, Jesper Bruno, Raphael Romano Dudzinski, David Artigas, Antonio Pinto, Bernardo Bollen Schefold, Joerg C. Wolff, Georg Kelm, Malte Beil, Michael Sigal, Sviri van Heerden, Peter Vernon Szczeklik, Wojciech Czuczwar, Miroslaw Elhadi, Muhammed Joannidis, Michael Oeyen, Sandra Zafeiridis, Tilemachos Marsh, Brian Andersen, Finn H. Moreno, Rui Cecconi, Maurizio Leaver, Susannah Boumendil, Ariane De Lange, Dylan W. Guidet, Bertrand Flaatten, Hans |
dc.subject.por.fl_str_mv |
Pulmonary and Respiratory Medicine |
topic |
Pulmonary and Respiratory Medicine |
description |
Funding Information: Support statement: This work was supported by the European Commission, APHP and Health Region West (Norway). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: C. Jung has nothing to disclose. B. Wernly has nothing to disclose. J. Fjølner has nothing to disclose. R.R. Bruno has nothing to disclose. D. Dudzinski has nothing to disclose. A. Artigas reports grants from Grifols and Fisher&Paykel, personal fees for advisory board work from Grifols, Novartis and Lilly Foundation, outside the submitted work. B. Bollen Pinto has nothing to disclose. J.C. Schefold has nothing to disclose. G. Wolff has nothing to disclose. M. Kelm has nothing to disclose. M. Beil has nothing to disclose. S. Sigal has nothing to disclose. P.V. van Heerden has nothing to disclose. W. Szczeklik has nothing to disclose. M. Czuczwar has nothing to disclose. M. Elhadi has nothing to disclose. M. Joannidis has nothing to disclose. S. Oeyen has nothing to disclose. T. Zafeiridis has nothing to disclose. B. Marsh has nothing to disclose. F.H. Andersen has nothing to disclose. R. Moreno has nothing to disclose. M. Cecconi has nothing to disclose. S. Leaver has nothing to disclose. A. Boumendil has nothing to disclose. D.W. De Lange has nothing to disclose. B. Guidet has nothing to disclose. H. Flaatten has nothing to disclose. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-03T05:03:06Z 2021-10-01 2021-10-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/127065 |
url |
http://hdl.handle.net/10362/127065 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
0903-1936 PURE: 34379126 https://doi.org/10.1183/13993003.00979-2021 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545827564912640 |